The Pharmacy Quality Alliance's 2022 annual meeting will return to an in-person format after 2 years. The meeting with include timely topics: quality beyond the pandemic, health equity, and remote care
The 2022 PQA Annual Meeting is May 3-5 at the Hilton Baltimore Inner Harbor in Baltimore, Maryland. Pharmacy Quality Alliance (PQA) is welcoming attendees in-person to the largest multidisciplinary gathering of health care quality professionals, who are focused on improving medication safety, adherence and appropriate use.
Open to all health care professionals, the meeting is a top forum for learning best practices and emerging trends in medication services, pharmacist-provided care and quality improvement initiatives.
“We are excited to welcome our members, sponsors and stakeholders back to an in-person annual meeting,” said PQA CEO Micah Cost, PharmD, MS. “PQA members have continued to partner with us and each other throughout the pandemic to improve the quality of care, but we all miss the personal connections and innovative ideas that emerge when we learn, network and engage together face-to-face.”
The 2022 meeting will be Cost’s first in-person PQA Annual Meeting since he joined the organization in February 2021. He will open the meeting with an address on the status and future direction of PQA’s work to improve medication use quality. He will then moderate the first general session, which is focused on access. The meeting’s 3 other general sessions are focused on timely topics for the industry: quality beyond the pandemic, health equity, and remote care.
“As we continue to navigate COVID-19–related challenges, it’s important to discuss the impact of the pandemic and the future of medication use quality,” said PQA Education Director Amanda Ryan, PharmD, BCGP, CPHQ. “That’s why value-based care, health equity, and pharmacist-provided care are the guiding concepts for this year’s meeting.”
In addition to the thought-provoking general sessions, the meeting includes 13 breakout sessions that build on these themes and address quality improvement and care delivery issues with cross-cutting industry perspectives. Continuing pharmacy education credits will be available for many of these sessions.
Quality improvement education is a hallmark of PQA meetings. This year’s meeting features a pre-conference, half-day workshop on May 3, Medication Use Quality: A PQA Live CE Event. The workshop is accredited for four hours of pharmacist continuing education and will cover the role of quality measurement in health care, quality measurement development and implementation, what makes a good measure and measurement programs.
Across the meeting, there are numerous opportunities to build business relationships and forge new partnerships in quality. A series of special sessions and innovation theaters will showcase successful approaches, technologies and emerging opportunities to improve medication services.
Rounding out the program is the PQA Annual Meeting Poster Session, which is sponsored by Pharmacy Quality Solutions. There will be 24 posters presented and awards presented, including one for best student poster.
The Annual Meeting registration fee is a low $399 for PQA members, $99 for students, and $999 for non-members, who register by April 4.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More